scholarly journals Evaluation of the Sub Acute Toxicity of the Stem Bark of Andira inermis

Author(s):  
Maxwell Osaronowen Egua ◽  
Florence Chimezie Nwinyi ◽  
Ode Julius Okwoche ◽  
Onakpa Micheal Monday ◽  
Akande Motunrayo Ganiyat ◽  
...  

The aqueous methanolic Andira inermis stem bark extract was screened in evaluation of its potential for its toxic effect in a 28 days study using the oral route only. The sub acute study was carried out in Wistar rats divided into 4 groups of 5 rats each; control group (a) received distilled water while the aqueous methanolic Andira inermis stem bark extract treatment groups (b), (c), and (d), received 100, 200, and 400 mg/kg of the extract respectively, for a period of 28 days, with their intake of feeds, water and signs of abnormality observed. At the end of the sub acute study, the rats were anaesthetized with chloroform and blood collected by cardiac puncture for biochemical and haematological evaluation. And the visceral organs (liver, kidneys, lungs, heart and spleen) excised for weighing and patho-morphological examination. The aqueous methanolic Andira inermis stem bark extract was found to; reduce the intake of water weekly, drop intake of feeds; significantly increased the red blood cell count (RBC), the haemoglobin concentration (HB), as well as the pack cell volume (PCV). The renal indices, showed the electrolytes sodium and chloride of the treatment groups (b, c and d) to be significantly different from the control. Urea was noticed to have reduce significantly and creatinine insignificantly. The organs weights across the Andira inermis treatment groups were noticed to be insignificantly (P › 0.05) different from the control for all the organs sampled (Lungs, Liver, Heart and Spleen) except for the kidney (organ weight which was noticed to have increased significantly). The patho-morphologies of the organs showed the heart to be normal, the kidney was normal in the control and the other treatment groups 100 mg 400 mg and 200 mg but a rat (an outlier) in one of the 200 mg group was noticed with tubular necrosis; the liver indicated a non concentration-dependent hepatitis while the lungs and the spleen presented an infective process.  It was concluded that, the aqueous methanolic extract of Andira inermis is a safe medicinal plant with the capacity to; raise red blood cell count (RBC), haemoglobin concentration (HB) as well as the pack cell volume (PCV); proffers a nephro- protective property; shrunken spleen; have a hepato-protective property and as well was non toxic to the heart and lungs. These findings warrants further pharmacognostic efficacy experimental research to harness the array of benefits of Andira inermis as discovered in this study.

2020 ◽  
Vol 151 ◽  
pp. 01011
Author(s):  
Safrida Safrida ◽  
Mustafa Sabri

This study was designed to determine the effect of Carica papaya L. stem bark extracts on cholesterol concentration in rats induced with glibenclamide. A completely randomized design was used for the experiment which consisted of 6 treatment groups, each group consisted of four rats, as follows:1) KN (negative control, non-diabetic rats); KP, diabetic rats given glibenclamide 10 mg/kg body weight; EP 1, diabetic rats given 0 mg/kg body weight/day extract; EP2, diabetic rats given 100 mg/kg body weight/day extract; and EP3, diabetic rats given 200 mg/kg body weight/day extract, EP4, diabetic rats given 300 mg/kg body weight/day extract for 28 day. The results showed that C. papaya L. stem bark extract decreased (P<0.05) cholesterol levels in diabetic rats. It was concluded that C. papaya L. stem bark extract had potential as anti-hypercholesterolemic in diabetic rats.


2019 ◽  
Vol 12 (1) ◽  
pp. 106-111
Author(s):  
Lilik Maslachah ◽  
Rahmi Sugihartuti ◽  
Retno Sri Wahyuni

Aim: This research aimed to determine the efficacy of Syzygium cumini L. as an adjuvant therapy on blood changes and splenic index of mice model malaria. Materials and Methods: Mice were infected intraperitoneally with 0.2 ml red blood cell (RBC) that contains 1×106 Plasmodium berghei. 35 mice were divided into seven treatment groups: Group K0: Mice were not infected; K1: Mice were infected; K2: Mice were infected and given chloroquine; P1: Mice were infected and given S. cumini leaf extract; P2: Mice were infected and given chloroquine and also S. cumini leaf extract; P3: Mice was infected and given S. cumini stem bark extract; and P4: Mice were infected and given chloroquine and S. cumini stem bark extract. Treatment was given for 4 days 24 h post-P. berghei infection. 21st day post-P. berghei infection, blood was taken from the heart for hematological examination, and the spleen was taken to examine the splenic index and also to measure the weight and length of the spleen. Hematological data and splenic index were analyzed by analysis of variance test, and if there is a difference, the test is continued by Duncan's multiple range test with 5% level. Results: The K0 group has normal hemoglobin (HGB), RBC, and hematocrit (HCT) and significantly different (p<0.05) than other groups. HGB, RBC, and HCT of K1 group were under normal range, lowest, and significantly different (p<0.05) than other groups. Mean corpuscular volume and mean corpuscular HGB values of K2 groups showed a decrease. The number of leukocytes, lymphocytes, and monocytes of K1 groups was increasing and significantly different (p<0.05) with K2 and treatment group. The length, width, weight, and splenic index of K1 group were significantly different (p<0.05) with K0 group. K2 and treatment groups showed that the length and width of spleens were significantly different (p<0.05) with K1. Conclusion: The combination of chloroquine with leaf and chloroquine with stem bark extract of S. cumini as adjuvant therapy may increase the amount of erythrocyte; decrease the number of leukocytes, lymphocytes, and monocytes; and decrease the length, width, and splenic index on malaria mice models.


2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Terhemen Festus Swem ◽  
Patrick Emeka Aba ◽  
Samuel Chukwuneke Udem

Abstract Background Burkea africana is a widely used medicinal plant in folkloric medicine in many developing countries of the world. It is useful in the treatment of various ailments including hepatitis, jaundice, diarrhea, stomach aches, abscesses, oedema, epilepsy, bloody diarrhea, gonorrhea, syphilis, toothaches and poisoning. Nevertheless, there are little or no scientific evidence to substantiate this medicinal claim by traditional healers. Burkea africana stem bark was therefore, investigated for its protective or stabilizing effect on erythrocyte membrane in acetaminophen-treated rats. B. africana stem bark was extracted using 80% methanol. Erythrocyte stabilizing effect was studied using erythrocyte osmotic fragility (EOF) test. Thirty (30) male rats were randomly assigned into five (5) groups of six (6) rats each. Groups 1 and 2 served as normal control and negative control (acetaminophen-treated group) respectively. Groups 3, 4 and 5 were pretreated with methanol stem bark extract of Burkea africana (MSBEBA) at doses of 200, 400 and 600 mg/kg body weight respectively once daily for seven (7) days. Blood samples were collected from the animals in all the groups on the 8 day for evaluation of packed cell volume, haemoglobin, red blood cell, white blood cell counts, and differential white blood cell count as well as erythrocyte osmotic fragility. Results The erythrocyte osmotic fragility test showed that there was a significantly (p < 0.05) low percentage hemolysis in the groups pre-treated with the extract when compared with the negative control. The percentage hemolysis was least at 600 mg/kg body weight of the extract. There was also a significant (p < 0.05) increase in the packed cell volume, haemoglobin, red blood cell count at all the doses of the extract used. Neutrophils were significantly (p < 0.05) decreased while lymphocytes were significantly increased in the groups administered MSBEBA 400 and 600 mg/kg body weight. Conclusion Methanol stem bark extract of Burkea africana had protective effect on the red blood cells and also improved haematological parameters. This indicates that Burkea africana may be useful in the treatment of disease conditions that results in hemolytic anemia by stabilizing red erythrocyte membranes and enhancing erythropoiesis.


Author(s):  
James F. Amaku ◽  
Segun A. Ogundare ◽  
Kovo G. Akpomie ◽  
Comfort M. Ngwu ◽  
Jeanet Conradie

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Camila Gabriel Kato-Schwartz ◽  
Anacharis Babeto de Sá-Nakanishi ◽  
Ana Carolina Guidi ◽  
Geferson de Almeida Gonçalves ◽  
Fernanda Giacomini Bueno ◽  
...  

2012 ◽  
Vol 5 (6) ◽  
pp. 314-321 ◽  
Author(s):  
A. Mohammed ◽  
S.B. Mada ◽  
H.M. Yakasai

Sign in / Sign up

Export Citation Format

Share Document